Dodgy Stem Cell Treatments, Questionable Practices Under Investigation
By Janene Pieters,
NL Times [Netherlands]
| 12. 23. 2015
Untitled Document
The Healthcare Inspectorate is investigating two commercial clinics in Amsterdam and Rotterdam where doctors treat chronically ill patients with stem cells taken from their own bone marrow or adipose tissue. There is no scientific proof that this treatment works, according to stem cell professors, the Volkskrant reports.
Stem cells have the ability to develop into all kinds of cells, which means that it holds the promise that it can repair damaged tissue. While stem cells from embryos show potential in scientific research, the evidence that this actually works is sill some way off, a number of experts told the Volkskrant. There is also hardly any results about treatments with stem cells from fat or bone marrow.
Another point of concern for the Healthcare Inspectorate is that private clinics, like the two clinics involved, are not allowed to perform stem cell treatments. Stem cell transplants fall under the Medical Procedures Act, and to perform any procedures under that act one needs a special permit. Only the Dutch Cancer Institute and university medical centers have such a permit.
The two...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...